Literature DB >> 32339034

Genomic Data Sharing for Novel Mendelian Disease Gene Discovery: The Matchmaker Exchange.

Danielle R Azzariti1, Ada Hamosh2.   

Abstract

In the last decade, exome and/or genome sequencing has become a common test in the diagnosis of individuals with features of a rare Mendelian disorder. Despite its success, this test leaves the majority of tested individuals undiagnosed. This review describes the Matchmaker Exchange (MME), a federated network established to facilitate the solving of undiagnosed rare-disease cases through data sharing. MME supports genomic matchmaking, the act of connecting two or more parties looking for cases with similar phenotypes and variants in the same candidate genes. An application programming interface currently connects six matchmaker nodes-the Database of Chromosomal Imbalance and Phenotype in Humans Using Ensembl Resources (DECIPHER), GeneMatcher, PhenomeCentral, seqr, MyGene2, and the Initiative on Rare and Undiagnosed Diseases (IRUD) Exchange-resulting in a collective data set spanning more than 150,000 cases from more than 11,000 contributors in 88 countries. Here, we describe the successes and challenges of MME, its individual matchmaking nodes, plans for growing the network, and considerations for future directions.

Entities:  

Keywords:  Matchmaker Exchange; candidate genes; data sharing; gene discovery; genomic matchmaking; rare diseases

Mesh:

Year:  2020        PMID: 32339034     DOI: 10.1146/annurev-genom-083118-014915

Source DB:  PubMed          Journal:  Annu Rev Genomics Hum Genet        ISSN: 1527-8204            Impact factor:   8.929


  18 in total

1.  Loss of Neuron Navigator 2 Impairs Brain and Cerebellar Development.

Authors:  Andrea Accogli; Shenzhao Lu; Ilaria Musante; Paolo Scudieri; Jill A Rosenfeld; Mariasavina Severino; Simona Baldassari; Michele Iacomino; Antonella Riva; Ganna Balagura; Gianluca Piccolo; Carlo Minetti; Denis Roberto; Fan Xia; Razaali Razak; Emily Lawrence; Mohamed Hussein; Emmanuel Yih-Herng Chang; Michelle Holick; Elisa Calì; Emanuela Aliberto; Rosalba De-Sarro; Antonio Gambardella; Undiagnosed Diseases Network; SYNaPS Study Group; Lisa Emrick; Peter J A McCaffery; Margaret Clagett-Dame; Paul C Marcogliese; Hugo J Bellen; Seema R Lalani; Federico Zara; Pasquale Striano; Vincenzo Salpietro
Journal:  Cerebellum       Date:  2022-02-26       Impact factor: 3.847

2.  Commentary on: Establishing the phenotypic spectrum of ZTTK syndrome by analysis of 52 individuals with variants in SON.

Authors:  Elizabeth Emma Palmer
Journal:  Eur J Hum Genet       Date:  2021-11-29       Impact factor: 4.246

3.  Clan genomics: From OMIM phenotypic traits to genes and biology.

Authors:  James R Lupski
Journal:  Am J Med Genet A       Date:  2021-08-18       Impact factor: 2.802

Review 4.  Precision medicine for genetic epilepsy on the horizon: Recent advances, present challenges, and suggestions for continued progress.

Authors:  Juliet K Knowles; Ingo Helbig; Cameron S Metcalf; Laura S Lubbers; Lori L Isom; Scott Demarest; Ethan M Goldberg; Alfred L George; Holger Lerche; Sarah Weckhuysen; Vicky Whittemore; Samuel F Berkovic; Daniel H Lowenstein
Journal:  Epilepsia       Date:  2022-07-17       Impact factor: 6.740

Review 5.  Centers for Mendelian Genomics: A decade of facilitating gene discovery.

Authors:  Samantha M Baxter; Jennifer E Posey; Nicole J Lake; Nara Sobreira; Jessica X Chong; Steven Buyske; Elizabeth E Blue; Lisa H Chadwick; Zeynep H Coban-Akdemir; Kimberly F Doheny; Colleen P Davis; Monkol Lek; Christopher Wellington; Shalini N Jhangiani; Mark Gerstein; Richard A Gibbs; Richard P Lifton; Daniel G MacArthur; Tara C Matise; James R Lupski; David Valle; Michael J Bamshad; Ada Hamosh; Shrikant Mane; Deborah A Nickerson; Heidi L Rehm; Anne O'Donnell-Luria
Journal:  Genet Med       Date:  2022-02-09       Impact factor: 8.864

6.  Clinical genomics and contextualizing genome variation in the diagnostic laboratory.

Authors:  James R Lupski; Pengfei Liu; Pawel Stankiewicz; Claudia M B Carvalho; Jennifer E Posey
Journal:  Expert Rev Mol Diagn       Date:  2020-10-10       Impact factor: 5.225

7.  Rare disease patient matchmaking: development and outcomes of an internet case-finding strategy in the Undiagnosed Diseases Network.

Authors:  Kimberly LeBlanc; Emily G Kelley; Anna Nagy; Jorick Bater; Tala Berro; Molly A McGuinness; Courtney Studwell; Matthew Might
Journal:  Orphanet J Rare Dis       Date:  2021-05-10       Impact factor: 4.123

Review 8.  Best practices for the interpretation and reporting of clinical whole genome sequencing.

Authors:  Christina A Austin-Tse; Vaidehi Jobanputra; Hutton M Kearney; Heidi L Rehm; Denise L Perry; David Bick; Ryan J Taft; Eric Venner; Richard A Gibbs; Ted Young; Sarah Barnett; John W Belmont; Nicole Boczek; Shimul Chowdhury; Katarzyna A Ellsworth; Saurav Guha; Shashikant Kulkarni; Cherisse Marcou; Linyan Meng; David R Murdock; Atteeq U Rehman; Elizabeth Spiteri; Amanda Thomas-Wilson
Journal:  NPJ Genom Med       Date:  2022-04-08       Impact factor: 6.083

Review 9.  Strategies to Uplift Novel Mendelian Gene Discovery for Improved Clinical Outcomes.

Authors:  Eleanor G Seaby; Heidi L Rehm; Anne O'Donnell-Luria
Journal:  Front Genet       Date:  2021-06-17       Impact factor: 4.599

10.  NGS-Based Diagnosis of Treatable Neurogenetic Disorders in Adults: Opportunities and Challenges.

Authors:  Jean-Marc Good; Isis Atallah; Mayte Castro Jimenez; David Benninger; Thierry Kuntzer; Andrea Superti-Furga; Christel Tran
Journal:  Genes (Basel)       Date:  2021-05-06       Impact factor: 4.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.